Ending the current distribution model for pharmaceutical drug samples (PDS) would have a disproportionate impact on disadvantaged populations, researchers wrote in a letter in JAAD. Instead, they said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback